Search

Your search keyword '"Abradelo M"' showing total 285 results
Start Over Author "Abradelo M"
285 results on '"Abradelo M"'

19. Pancreaticoduodenectomy in octogenarians: a retrospective case-control study

Author

Attard, J., primary, Salinas, C Hidalgo, additional, Pathanki, A., additional, Roberts, K., additional, Sutcliffe, R., additional, Marudanayagam, R., additional, Muiesan, P., additional, Mirza, D., additional, Abradelo, M., additional, Dasari, B., additional, Isaac, J., additional, Davidson, B., additional, Sharma, D., additional, Imber, C., additional, Malago, M., additional, Rahman, Z., additional, Fusai, G., additional, and Chatzizacharias, N., additional

Published
2020
Full Text
View/download PDF

20. Discordance in the distributions of anatomical liver volume and the liver function measured on scintigraphy in the future liver remnant using 99m Technetium -Mebrofinate SPECT-CT scan

Author

Dasari, B., primary, Wilson, M., additional, Guest, P., additional, Marudanayagam, R., additional, Roberts, K., additional, Sutcliffe, R., additional, Chatzacharias, N., additional, Abradelo, M., additional, Mirza, D., additional, Muiesan, P., additional, and Isaac, J., additional

Published
2020
Full Text
View/download PDF

22. Early experience of an integrated liver fuctional assessment pathway using 99m Tc -Mebrofinate SPECT-CT scan, ICG, Elastography and HVPG of patients planned for major liver resection

Author

Dasari, B., primary, Wilson, M., additional, Guest, P., additional, Marudanayagam, R., additional, Roberts, K., additional, Sutcliffe, R., additional, Chatzacharias, N., additional, Abradelo, M., additional, Tripathi, D., additional, Mirza, D., additional, Muiesan, P., additional, and Isaac, J., additional

Published
2020
Full Text
View/download PDF

36. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

Author

Aga¼ero, F., Rimola, A., Stock, P., Grossi, P., Rockstroh, J. K., Agarwal, K., Garzoni, C., Barcan, L. A., Maltez, F., Manzardo, C., Mari, M., Ragni, M. V., Anadol, E., Di Benedetto, F., Nishida, S., Gastaca, M., Mira, J. M., Pedreira, J. D., Castro, M. A., Lapez, S., Sua¡rez, F., Vazquez, P., Blanch, J., Brunet, M., Cervera, C., de Lazzari, E., Fondevila, C., Forner, A., Fuster, J., Freixa, N., GarcA­a-Valdecasas, J. C., Gil, A., Gatell, J. M., Laguno, M., Marta­nez, M., Mallolas, J., Monras, M., Moreno, A., Murillas, J., Paredes, D., Pacopyrightrez, I., Torres, F., Tural, C., Tuset, M., Antela, A., Fernandez, J., Losada, E., Varo, E., Lozano, R., Araiz, J. J., Barrao, E., Letona, S., Luque, P., Navarro, A., Sanjoaqua­n, I., Serrano, T., Tejero, E., Salcedo, M., BaA+/-ares, R., Calleja, J., Berenguer, J., Cosa­n, J., Gutiacopyrightrrez, I., Lapez, J. C., Miralles, P., Rama­rez, M., Rincan, D., Sanchez, M., Jimacopyrightnez, M., de la Cruz, J., Ferna¡ndez, J. L., Lozano, J. M., Santoyo, J., Rodrigo, J. M., Sua¡rez, M. A., Rodra­guez, M., Alonso, M. P., Asensi, V., Gonza¡lez, M. L., GonzA¡lez-Pinto, I., Rafecas, A., Carratala¡, J., Fabregat, J., Ferna¡ndez, N., Xiol, X., Montejo, M., Bustamante, J., Ferna¡ndez, J. R., Montejo, E., Ortiz de Urbina, J., Ruiz, P., Sua¡rez, M. J., Testillano, M., Valdivieso, A., Ventoso, A., Abradelo, M., Costa, J. R., Fundora, Y., Jimacopyrightnez, S., Meneu, J. C., Moreno, E., Moreno, V., Olivares, S. P., Pacopyrightrez, B., Pulido, F., Rubio, R., Blanes, M., Aguilera, V., Berenguer, M., Lapez, J., Lapez, R., Prieto, M., FariA+/-as, M. C., Arnaiz, A., Casafont, F., Echevarria, S., Fa¡brega, E., Garca­a, J. D., Gamez, M., Gutiacopyrightrrez, J. M., Peralta, F. G., Teira, R., Moreno, S., Barcena, R., Del Campo, S., Fortaºn, J., Moreno, A. M., Torre-Cisneros, J., Barrera, P., Camacho, A., Cantisa¡n, S., Castan, J. J., de la Mata, M., Lara, M. R., Natera, C., Rivero, A., Vidal, E., Castells, L. I., Charco, R., Esteban, J. I., Gavalda¡, J., Len, O., Pahissa, A., Ribera, E., Vargas, V., Pons, J. A., Cordero, E., Bernal, C., Cisneros, J. M., Gamez, M. A., Pascasio, J. M., Rodra­guez, M. J., Sayazo, M., Sousa, J. M., Sua¡rez, G., Gonza¡lez, J., Aznar, E., Barquilla, E., Esteban, H., Krahe, L., Moyano, B., de la Rosa, G., Mahillo, B., Roland, M., Ascher, N., Roberts, J., Freise, C., Terrault, N., Carlson, L., Beatty, G., Chin-Hong, P., Dove, L., Emond, J., Lobritto, S., Neu, N., Yin, M., Kumar, A., Ringe, B., Jacobson, J., Sass, D., Diego, J., Tzakis, A., Roth, D., Schiff, E., Burke, G., Jayaweera, D., Olthoff, K., Blumberg, E., Bloom, R., Reddy, R., Ragni, M., Shapiro, R., De Vera, M. E., Shakil, O., Simon, D., Cohen, S. M., Dodson, S. F., Jensik, S., Saltzberg, S., Stosor, T., Green, R., Baker, T., Gallon, L., Scarsi, K., Hanto, D., Wong, M., Curry, M., Johnson, S., Pavlakis, M., Barin, B., Risaliti, A., Ancarani, F., Pinna, A. D., Morelli, C., Guaraldi, G., Tarantino, G., Baccarani, U., Tavio, M., Nanni Costa, A., Beckebaum, S., Radecke, K., Bickel, M., Sterneck, M., Zoufaly, A., Ganten, T., Stoll, M., Salzberger, B., Berg, C., Kittner, J., O'Grady, J., Joshi, D., Heaton, N., Smud, A., Genoud, N., Cahn, F., Valledor, A., Gadano, A., Barcan, L., Cusini, A., Rauch, A., Furrer, H., Ma¼ller, N. J., Khanna, N., van Delden, C., Oriol, M., Manata, M. J., Correia, F., Machado, J., Morbey, A., Glaria, H., Veloso, J., Perdigoto, R., Pereira, P., Martins, A., and Barroso, E.

Subjects
Male, medicine.medical_treatment, HCC INF, HIV Infections, Hepacivirus, 030230 surgery, Liver transplantation, medicine.disease_cause, Gastroenterology, Cohort Studies, 0302 clinical medicine, Postoperative Complications, Risk Factors, Adult, Coinfection, Female, Follow-Up Studies, Graft Survival, HIV-1, Hepatitis B, Hepatitis B virus, Hepatitis C, Humans, International Agencies, Middle Aged, Prognosis, Reoperation, Survival Rate, Liver Transplantation, Immunology and Allergy, Transplantation, Pharmacology (medical), virus diseases, 3. Good health, 030211 gastroenterology & hepatology, medicine.medical_specialty, Hepatitis C virus, 03 medical and health sciences, Internal medicine, medicine, Survival rate, business.industry, medicine.disease, digestive system diseases, Surgery, business
Abstract

Liver retransplantation is performed in HIV-infected patients, although its outcome is not well known. In an international cohort study (eight countries), 37 (6%; 32 coinfected with hepatitis C virus [HCV] and five with hepatitis B virus [HBV]) of 600 HIV-infected patients who had undergone liver transplant were retransplanted. The main indications for retransplantation were vascular complications (35%), primary graft nonfunction (22%), rejection (19%), and HCV recurrence (13%). Overall, 19 patients (51%) died after retransplantation. Survival at 1, 3, and 5 years was 56%, 51%, and 51%, respectively. Among patients with HCV coinfection, HCV RNA replication status at retransplantation was the only significant prognostic factor. Patients with undetectable versus detectable HCV RNA had a survival probability of 80% versus 39% at 1 year and 80% versus 30% at 3 and 5 years (p = 0.025). Recurrence of hepatitis C was the main cause of death in the latter. Patients with HBV coinfection had survival of 80% at 1, 3, and 5 years after retransplantation. HIV infection was adequately controlled with antiretroviral therapy. In conclusion, liver retransplantation is an acceptable option for HIV-infected patients with HBV or HCV coinfection but undetectable HCV RNA. Retransplantation in patients with HCV replication should be reassessed prospectively in the era of new direct antiviral agents. info:eu-repo/semantics/publishedVersion

Published
2016

38. Ledipasvir/Sofosbuvir for Recurrent Hepatitis C in Liver Transplant Recipients: A Real-Life Spanish Multicentre Experience

Author

Prieto, M., primary, Fernández, I., additional, Londoño, M.-C., additional, Abradelo, M., additional, Pascasio, J.M., additional, Gea, F., additional, Rincón, D., additional, Cuervas-Mons, V., additional, Crespo, G., additional, Montero, J.L., additional, Hontangas, V., additional, Baliellas, C., additional, Sousa, J.M., additional, García, M., additional, Pascual, S., additional, Pons, J.A., additional, Castells, L., additional, Testillano, M., additional, Jimenez, M., additional, Otero, A., additional, Molina, E., additional, González, A., additional, Nogueras, F., additional, González-Dieguez, L., additional, Lorente, S., additional, Sánchez-Antolín, G., additional, Herrero, J.I., additional, and Casafont, F., additional

Published
2016
Full Text
View/download PDF

39. Direct‐acting antivirals are effective and safe in HCV/HIV‐coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

Author

Manzardo, Christian, Londoño, Maria C., Castells, LLuís, Testillano, Milagros, Luis Montero, José, Peñafiel, Judit, Subirana, Marta, Moreno, Ana, Aguilera, Victoria, Luisa González‐Diéguez, María, Calvo‐Pulido, Jorge, Xiol, Xavier, Salcedo, Magdalena, Cuervas‐Mons, Valentin, Manuel Sousa, José, Suarez, Francisco, Serrano, Trinidad, Ignacio Herrero, Jose, Jiménez, Miguel, Fernandez, José R., Giménez, Carlos, del Campo, Santos, Esteban‐Mur, Juan I., Crespo, Gonzalo, Moreno, Asunción, de la Rosa, Gloria, Rimola, Antoni, Miro, Jose M., Suárez, F., Castro, M.A., López, S., Pedreira, J.D., Vázquez, P., Agüero, F., Blanch, J., Brunet, M., Calatayud, D., Cervera, C., Lazzari, E., Fondevila, C., Forner, A., Fuster, J., Forns, X., Gil, A., Gatell, J.M., Laguno, M., Lligoña, A., Mallolas, J., Murillas, J., Navasa, M., Paredes, D., Pérez, I., Torres, F., Tural, C., Tuset, M., Antela, A., Losada, E., Molina, E., Otero, E., Varo, E., Araiz, J.J, Barrao, E., Larraga, J., Letona, S., Lozano, R., Luque, P., Navarro, A., Sanjoaquín, I., Tejero, E., Bañares, R., Berenguer, J., Clemente, G., Cosín, J., Ferreiroa, J.P, García‐Sabrido, J.L., Gutiérrez, I., López, J.C., Miralles, P., Ramírez, M., Rincón, D., Sánchez, M., Cruz, J., Fernández, J.L., Lozano, J.M., Santoyo, J., Rodrigo, J.M., Suárez, M.A., Rodríguez, M., Alonso, M.P., Asensi, V., González‐Pinto, I., Rafecas, A., Baliellas, C., Carratalá, J., Fabregat, J., Fernández, N., Jorba, R., Lladó, L., Montejo, M., Bustamante, J., Fernández, J.R., Gastaca, M., González, J., Montejo, E., Ortiz de Urbina, J., Ruiz, P., Suárez, M.J., Valdivieso, A., Ventoso, A., Abradelo, M., Calvo, J., Costa, J.R., García‐Sesma, A., Jiménez, C., Manrique, A., Meneu, J.C., Moreno, E., Moreno, V., Olivares, S.P., Pulido, F., Rubio, R., Blanes, M., Berenguer, M., López, J., López, R., Prieto, M., Fariñas, M.C., Casafont, F., Echevarria, S., Fábrega, E., Gomez‐Fleitas, M., Armiñanzas, C., Herrera‐Noreña, J.L., Moreno, S., Barcena, R., Fortún, J., Moreno, A.M., Martín‐Dávila, P., Torre‐Cisneros, J., Barrera, P., Briceño, J., Caston, J.J., Costan, G., Mata, M., Lara, R., López‐Cillero, P., Rivero, A., Rufian, S., Sánchez‐Antolín, G., García Pajares, F., Bachiller, P., Almohalla, C., Barrera, A., Conde, R., Bilbao, I., Campos‐Varela, I., Charco, R., Esteban, J.I., Gavaldá, J., Len, O., Pahissa, A., Ribera, E., Vargas, V., Pons, J.A., Cordero, E., Bernal, C., Cisneros, J.M., Gómez, M.A., Pascasio, J.M., Rodríguez, M.J., Sayago, M., Suárez, G., González‐García, J., Aznar, E., Esteban, H., Moyano, B., Garrido, G., Mahillo, B., Matesanz, R., Guerra, L., Manzanera, M., and Samuel, D.

Abstract

Direct‐acting antivirals have proved to be highly efficacious and safe in monoinfected liver transplant (LT) recipients who experience recurrence of hepatitis C virus (HCV) infection. However, there is a lack of data on effectiveness and tolerability of these regimens in HCV/HIV‐coinfected patients who experience recurrence of HCV infection after LT. In this prospective, multicenter cohort study, the outcomes of 47 HCV/HIV‐coinfected LT patients who received DAA therapy (with or without ribavirin [RBV]) were compared with those of a matched cohort of 148 HCV‐monoinfected LT recipients who received similar treatment. Baseline characteristics were similar in both groups. HCV/HIV‐coinfected patients had a median (IQR) CD4 T‐cell count of 366 (256‐467) cells/µL. HIV‐RNA was <50 copies/mL in 96% of patients. The DAA regimens administered were SOF + LDV ± RBV (34%), SOF + SMV ± RBV (31%), SOF + DCV ± RBV (27%), SMV + DCV ± RBV (5%), and 3D (3%), with no differences between the groups. Treatment was well tolerated in both groups. Rates of SVR (negative serum HCV‐RNA at 12 weeks after the end of treatment) were high and similar for coinfected and monoinfected patients (95% and 94%, respectively; P= .239). Albeit not significant, a trend toward lower SVR rates among patients with advanced fibrosis (P= .093) and genotype 4 (P= .088) was observed. In conclusion, interferon‐free regimens with DAAs for post‐LT recurrence of HCV infection in HIV‐infected individuals were highly effective and well tolerated, with results comparable to those of HCV‐monoinfected patients. Direct‐acting antivirals against HCV offer a very high and similar efficacy and safety in HIV‐positive and HIV‐negative liver transplant recipients.

Published
2018
Full Text
View/download PDF

48. Liver graft recipients with more than five years of follow up

Author

Loinaz C, Abradelo M, Gomez R, G. lez Pinto I, Garcia I, Moreno Gonzalez E., MUSELLA, MARIO, Loinaz, C, Musella, Mario, Abradelo, M, Gomez, R, G., lez Pinto I, Garcia, I, and Moreno Gonzalez, E.

Subjects
Liver transplantation, liver graft, recipient, follow-up
Published
1995

Catalog

Books, media, physical & digital resources
See catalog results